Astrazeneca Pharma India Ltd Competitors & Peer Comparison
Pharmaceuticals · Indian listed companies
Compare Astrazeneca Pharma India Ltd with 125 companies shown from the same industry classification, including Marksans Pharma Ltd, Natco Pharma Ltd, Concord Biotech Ltd. These are industry peers; their products, customers and business models may differ.
Selected-company price and ratio data: . Peer reporting dates can differ. Stored figures, not live quotes.
Compare valuation, size and returns
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca Pharma India Ltd | 15,465 Cr. | 6,186 | 9,850/6,120 | 89.2 | 349 | 0.58 % | 29.3 % | 23.3 % | 2.00 |
| Marksans Pharma Ltd | 15,530 Cr. | 343 | 351/155 | 30.0 | 66.7 | 0.26 % | 18.8 % | 15.2 % | 1.00 |
| Natco Pharma Ltd | 15,109 Cr. | 843 | 1,227/789 | 13.2 | 515 | 0.59 % | 17.4 % | 17.1 % | 2.00 |
| Concord Biotech Ltd | 14,743 Cr. | 1,411 | 1,668/987 | 51.8 | 193 | 0.54 % | 17.4 % | 12.6 % | 1.00 |
| Alembic Pharmaceuticals Ltd | 16,253 Cr. | 825 | 998/635 | 21.8 | 289 | 1.45 % | 12.6 % | 13.4 % | 2.00 |
| Jubilant Pharmova Ltd | 16,748 Cr. | 1,048 | 1,185/784 | 43.2 | 445 | 0.48 % | 8.99 % | 6.53 % | 1.00 |
| ERIS Lifesciences Ltd | 16,920 Cr. | 1,219 | 1,740/1,180 | 25.8 | 282 | 0.59 % | 14.1 % | 18.7 % | 1.00 |
| Cohance Lifesciences Ltd | 17,496 Cr. | 458 | 918/267 | 162 | 102 | 0.00 % | 5.81 % | 4.89 % | 1.00 |
| Pfizer Ltd | 17,902 Cr. | 3,913 | 5,578/3,887 | 23.3 | 919 | 1.92 % | 24.1 % | 18.0 % | 10.0 |
| Blue Jet Healthcare Ltd | 10,407 Cr. | 550 | 693/325 | 44.3 | 78.4 | 0.22 % | 26.1 % | 19.4 % | 2.00 |
| Caplin Point Laboratories Ltd | 20,652 Cr. | 2,716 | 2,991/1,500 | 31.0 | 443 | 0.29 % | 24.2 % | 20.9 % | 2.00 |
| Shilpa Medicare Ltd | 20,690 Cr. | 1,056 | 1,076/260 | 72.8 | 132 | 0.06 % | 10.9 % | 8.99 % | 1.00 |
| Procter & Gamble Health Ltd | 9,444 Cr. | 5,696 | 6,975/4,700 | 28.3 | 316 | 2.72 % | 83.9 % | 61.9 % | 10.0 |
| Suven Life Sciences Ltd | 9,171 Cr. | 325 | 403/124 | 22.4 | 0.00 % | 79.5 % | 81.5 % | 1.00 | |
| Aarti Pharmalabs Ltd | 8,821 Cr. | 973 | 985/584 | 41.0 | 234 | 0.36 % | 10.7 % | 8.59 % | 5.00 |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Entero Healthcare Solutions Ltd | 7,671 Cr. | 1,765 | 1,920/944 | 59.4 | 388 | 0.00 % | 10.5 % | 6.94 % | 10.0 |
| Bliss GVS Pharma Ltd | 7,393 Cr. | 694 | 745/118 | 53.7 | 113 | 0.22 % | 16.9 % | 11.8 % | 1.00 |
| Granules India Ltd | 23,706 Cr. | 867 | 924/511 | 36.5 | 205 | 0.20 % | 15.5 % | 13.8 % | 1.00 |
| Sanofi India Ltd | 7,076 Cr. | 3,072 | 4,898/3,049 | 20.6 | 359 | 2.44 % | 57.5 % | 43.0 % | 10.0 |
| Morepen Laboratories Ltd | 6,516 Cr. | 119 | 127/33.0 | 55.5 | 22.8 | 0.17 % | 8.05 % | 5.33 % | 2.00 |
| Orchid Pharma Ltd | 6,077 Cr. | 1,015 | 1,144/471 | 336 | 300 | 0.00 % | 1.86 % | 1.49 % | 10.0 |
| IOL Chemicals & Pharmaceuticals Ltd | 5,911 Cr. | 201 | 219/67.1 | 33.5 | 61.3 | 0.50 % | 11.3 % | 8.42 % | 2.00 |
| FDC Ltd | 5,712 Cr. | 350 | 476/313 | 18.6 | 153 | 1.43 % | 15.4 % | 11.2 % | 1.00 |
| Gujarat Themis Biosyn Ltd | 5,292 Cr. | 406 | 479/225 | 109 | 26.4 | 0.16 % | 18.1 % | 17.4 % | 1.00 |
| RPG Life Sciences Ltd | 5,113 Cr. | 3,089 | 3,130/1,731 | 43.8 | 366 | 0.78 % | 25.7 % | 19.3 % | 8.00 |
| Zota Health Care Ltd | 4,503 Cr. | 1,300 | 1,740/1,022 | 200 | 0.08 % | 8.47 % | 15.0 % | 10.0 | |
| SMS Pharmaceuticals Ltd | 4,494 Cr. | 479 | 494/240 | 49.6 | 85.9 | 0.08 % | 12.9 % | 11.9 % | 1.00 |
| Gufic BioSciences Ltd | 4,368 Cr. | 436 | 468/268 | 59.4 | 66.2 | 0.02 % | 12.2 % | 9.98 % | 1.00 |
| Unichem Laboratories Ltd | 3,997 Cr. | 568 | 687/278 | 32.7 | 386 | 0.00 % | 4.13 % | 3.17 % | 2.00 |
| Aarti Drugs Limited | 3,910 Cr. | 431 | 534/319 | 22.6 | 154 | 0.46 % | 11.7 % | 12.7 % | 10.0 |
| Acutaas Chemicals Ltd | 27,060 Cr. | 3,304 | 3,740/1,290 | 70.1 | 202 | 0.08 % | 31.6 % | 24.0 % | 5.00 |
| Kwality Pharmaceuticals Ltd | 3,758 Cr. | 3,625 | 3,949/829 | 46.0 | 321 | 0.00 % | 23.9 % | 22.5 % | 10.0 |
| Solara Active Pharma Sciences Ltd | 3,635 Cr. | 750 | 774/422 | 851 | 346 | 0.00 % | 4.86 % | 0.13 % | 10.0 |
| Ind-Swift Laboratories Ltd | 3,591 Cr. | 413 | 420/87.0 | 55.2 | 159 | 0.00 % | 4.86 % | 4.02 % | 10.0 |
| Neuland Laboratories Ltd | 27,433 Cr. | 21,375 | 24,235/11,500 | 55.1 | 1,461 | 0.16 % | 26.5 % | 21.2 % | 10.0 |
| Advanced Enzyme Technologies Ltd | 3,149 Cr. | 282 | 420/252 | 20.0 | 146 | 1.90 % | 14.0 % | 10.2 % | 2.00 |
| Hikal Ltd | 2,682 Cr. | 218 | 261/146 | 63.2 | 97.2 | 0.28 % | 3.50 % | 2.21 % | 2.00 |
| Dishman Carbogen Amcis Ltd | 2,528 Cr. | 161 | 307/128 | 139 | 426 | 0.00 % | 3.14 % | 1.58 % | 2.00 |
| Indoco Remedies Ltd | 2,484 Cr. | 269 | 317/162 | 102 | 0.07 % | 0.96 % | 9.36 % | 2.00 | |
| Syncom Formulations (India) Ltd | 2,461 Cr. | 26.2 | 26.6/10.2 | 29.0 | 4.39 | 0.38 % | 24.8 % | 17.6 % | 1.00 |
| Fredun Pharmaceuticals Ltd | 2,301 Cr. | 1,392 | 1,600/427 | 51.8 | 170 | 0.02 % | 21.5 % | 15.8 % | 10.0 |
| Panacea Biotec Ltd | 2,290 Cr. | 375 | 648/292 | 136 | 0.00 % | 2.43 % | 2.42 % | 1.00 | |
| Venus Remedies Ltd | 2,284 Cr. | 1,711 | 2,044/424 | 19.7 | 497 | 0.58 % | 20.7 % | 15.6 % | 10.0 |
| Beta Drugs Ltd | 2,276 Cr. | 2,053 | 2,808/990 | 49.9 | 241 | 0.00 % | 19.2 % | 18.8 % | 10.0 |
| Hester Biosciences Ltd | 1,848 Cr. | 2,165 | 2,684/1,239 | 34.8 | 423 | 0.51 % | 15.2 % | 15.9 % | 10.0 |
| Fermenta Biotech Ltd | 1,629 Cr. | 551 | 580/249 | 29.8 | 138 | 0.68 % | 20.6 % | 16.4 % | 5.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,552 Cr. | 235 | 265/155 | 33.0 | 41.2 | 1.70 % | 22.7 % | 17.3 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,486 Cr. | 515 | 760/476 | 23.9 | 128 | 0.95 % | 24.8 % | 18.4 % | 1.00 |
| TTK Healthcare Ltd | 1,460 Cr. | 1,034 | 1,250/735 | 19.1 | 789 | 0.97 % | 8.04 % | 6.30 % | 10.0 |
| Kopran Ltd | 1,399 Cr. | 291 | 294/107 | 56.0 | 110 | 1.03 % | 6.65 % | 4.91 % | 10.0 |
| Lincoln Pharmaceuticals Ltd | 1,170 Cr. | 584 | 770/440 | 12.1 | 378 | 0.31 % | 16.3 % | 12.3 % | 10.0 |
| Themis Medicare Ltd | 1,103 Cr. | 120 | 147/65.0 | 43.3 | 0.42 % | 2.74 % | 0.41 % | 1.00 | |
| Anuh Pharma Ltd | 897 Cr. | 89.7 | 99.5/66.7 | 20.3 | 35.1 | 1.67 % | 14.9 % | 10.7 % | 5.00 |
| Bafna Pharmaceuticals Ltd | 864 Cr. | 371 | 378/94.8 | 111 | 40.6 | 0.00 % | 11.9 % | 12.3 % | 10.0 |
| Wanbury Ltd | 760 Cr. | 217 | 360/162 | 17.7 | 18.1 | 0.00 % | 36.6 % | 76.5 % | 10.0 |
| Kilitch Drugs (India) Ltd | 747 Cr. | 217 | 234/117 | 24.8 | 80.0 | 0.00 % | 13.4 % | 10.6 % | 10.0 |
| Albert David Ltd | 497 Cr. | 872 | 932/580 | 22.0 | 686 | 0.57 % | 0.82 % | 0.44 % | 10.0 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Aarey Drugs & Pharmaceuticals Ltd | 310 Cr. | 99.9 | 104/50.3 | 74.2 | 53.0 | 0.00 % | 5.58 % | 2.75 % | 10.0 |
| Lyka Labs Ltd | 298 Cr. | 82.5 | 105/44.1 | 25.9 | 0.00 % | 5.98 % | 10.2 % | 10.0 | |
| BDH Industries Ltd | 288 Cr. | 500 | 610/340 | 24.6 | 134 | 1.00 % | 20.5 % | 14.8 % | 10.0 |
| Gennex Laboratories Ltd | 245 Cr. | 10.1 | 17.2/7.05 | 13.0 | 9.16 | 0.00 % | 11.8 % | 10.5 % | 1.00 |
| Everest Organics Ltd | 222 Cr. | 223 | 536/197 | 42.2 | 77.7 | 0.00 % | 12.0 % | 7.63 % | 10.0 |
| Nectar Lifescience Ltd | 207 Cr. | 10.7 | 22.5/9.20 | 30.0 | 0.00 % | 0.05 % | 31.3 % | 1.00 | |
| Ambalal Sarabhai Enterprises Ltd | 203 Cr. | 26.5 | 42.0/23.1 | 11.4 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Coral Laboratories Ltd | 195 Cr. | 545 | 679/360 | 10.3 | 585 | 0.37 % | 11.0 % | 7.79 % | 10.0 |
| Bal Pharma Ltd | 175 Cr. | 110 | 125/59.7 | 24.3 | 51.6 | 1.10 % | 9.69 % | 7.87 % | 10.0 |
| Brooks Laboratories Ltd | 161 Cr. | 55.8 | 138/36.3 | 12.2 | 41.6 | 0.00 % | 21.2 % | 22.0 % | 10.0 |
| Par Drugs & Chemicals Ltd | 154 Cr. | 125 | 180/78.0 | 10.6 | 91.0 | 0.00 % | 14.6 % | 9.95 % | 10.0 |
| Auro Laboratories Ltd | 153 Cr. | 245 | 317/159 | 31.9 | 74.4 | 0.00 % | 9.52 % | 8.49 % | 10.0 |
| Achyut Healthcare Ltd | 151 Cr. | 6.24 | 10.0/4.70 | 471 | 1.45 | 0.00 % | 1.18 % | 0.96 % | 1.00 |
| Gujarat Inject (Kerala) Ltd | 142 Cr. | 9.68 | 14.3/1.96 | 47.3 | 0.81 | 0.00 % | 22.9 % | 16.6 % | 1.00 |
| Godavari Drugs Ltd | 132 Cr. | 120 | 135/69.7 | 33.8 | 74.8 | 0.00 % | 6.55 % | 6.14 % | 10.0 |
| Lactose (India) Ltd | 132 Cr. | 105 | 136/76.0 | 19.0 | 51.5 | 0.00 % | 11.3 % | 9.81 % | 10.0 |
| Alpa Laboratories Ltd | 124 Cr. | 59.5 | 99.8/46.0 | 28.3 | 93.4 | 0.00 % | 8.91 % | 7.90 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 124 Cr. | 56.4 | 76.8/38.3 | 75.5 | 0.00 % | 15.4 % | % | 10.0 | |
| Vaishali Pharma Ltd | 109 Cr. | 8.39 | 11.9/4.75 | 25.8 | 5.29 | 0.00 % | 8.93 % | 6.02 % | 2.00 |
| Pharmaids Pharmaceuticals Ltd | 105 Cr. | 29.8 | 66.0/25.6 | 13.5 | 0.00 % | 18.5 % | 26.5 % | 10.0 | |
| Concord Drugs Ltd | 103 Cr. | 78.3 | 92.5/61.0 | 50.5 | 36.8 | 0.00 % | 5.19 % | 2.52 % | 10.0 |
| Denis Chem Lab Ltd | 94.6 Cr. | 68.1 | 97.4/56.1 | 11.8 | 66.0 | 3.67 % | 14.0 % | 9.52 % | 10.0 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | / | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Fervent Synergies Ltd | 76.4 Cr. | 15.3 | 26.0/13.0 | 21.0 | 11.4 | 0.00 % | 7.21 % | 7.22 % | 10.0 |
| Cian Healthcare Ltd | 58.8 Cr. | 23.5 | 23.5/4.72 | 3.42 | 0.00 % | 15.1 % | 49.2 % | 10.0 | |
| ANG Lifesciences India Ltd | 52.6 Cr. | 40.2 | 49.7/17.6 | 47.6 | 0.00 % | 0.95 % | 7.33 % | 10.0 | |
| Mangalam Drugs and Organics Ltd | 49.6 Cr. | 31.4 | 74.0/22.7 | 65.3 | 0.00 % | 14.0 % | 34.8 % | 10.0 | |
| Biofil Chemicals & Pharmaceuticals Ltd | 49.0 Cr. | 30.4 | 46.8/25.6 | 102 | 13.2 | 0.00 % | 2.97 % | 2.83 % | 10.0 |
| Vivimed Labs Ltd | 48.7 Cr. | 5.55 | 29.4/4.75 | 25.4 | 0.00 % | 65.2 % | % | 2.00 | |
| Bharat Immunological & Biological Corporation Ltd | 43.5 Cr. | 10.1 | 22.6/9.90 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
| Murae Organisor Ltd | 38.8 Cr. | 0.19 | 0.57/0.19 | 2.56 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Bacil Pharma Ltd | 37.5 Cr. | 26.1 | 61.8/10.6 | 57.7 | 17.3 | 0.00 % | 3.93 % | 6.21 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 37.3 Cr. | 49.4 | 53.0/29.7 | 12.2 | 43.9 | 0.00 % | 12.1 % | 9.67 % | 10.0 |
| Gujarat Terce Laboratories Ltd | 28.2 Cr. | 36.2 | 59.8/29.0 | 12.7 | 12.5 | 0.00 % | 39.2 % | 30.2 % | 10.0 |
| Checkpoint Trends Ltd | 17.1 Cr. | 31.2 | 144/28.4 | 13.9 | 42.5 | 0.00 % | 15.0 % | 12.7 % | 10.0 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
| Desh Rakshak Aushdhalaya Ltd | 15.3 Cr. | 26.9 | 59.6/22.4 | 27.9 | 23.3 | 0.00 % | 7.50 % | 5.59 % | 10.0 |
| Beryl Drugs Ltd | 12.4 Cr. | 24.6 | 27.6/15.9 | 20.1 | 19.5 | 0.00 % | 7.25 % | 4.34 % | 10.0 |
| Dipna Pharmachem Ltd | 11.9 Cr. | 4.52 | 25.0/3.90 | 4.52 | 23.7 | 0.00 % | 7.64 % | 5.22 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 11.6 Cr. | 77.4 | 153/70.0 | 8.60 | 0.00 % | 0.28 % | 0.28 % | 10.0 | |
| Colinz Laboratories Ltd | 9.44 Cr. | 75.0 | 87.9/36.1 | 18.9 | 39.9 | 0.00 % | 7.20 % | 5.23 % | 10.0 |
| Adline Chem Lab Ltd | 8.80 Cr. | 15.0 | 17.1/7.60 | 3.03 | 0.00 % | 1,267 % | % | 10.0 | |
| Ganga Pharmaceuticals Ltd | 7.39 Cr. | 12.5 | 14.0/9.35 | 73.9 | 14.1 | 0.00 % | 2.90 % | 1.30 % | 10.0 |
| Brawn Biotech Ltd | 6.74 Cr. | 22.4 | 24.4/17.7 | 7.93 | 14.5 | 0.00 % | 0.00 % | 24.4 % | 10.0 |
| Decipher Labs Ltd | 6.21 Cr. | 6.15 | 11.0/5.00 | 20.5 | 0.00 % | 16.7 % | 14.2 % | 10.0 | |
| Amerise Biosciences Ltd | 5.61 Cr. | 0.85 | 1.03/0.50 | 0.82 | 0.00 % | 0.37 % | 0.37 % | 1.00 | |
| Fabino Enterprises Ltd | 4.27 Cr. | 20.3 | 27.0/13.0 | 18.7 | 0.00 % | 6.22 % | 8.76 % | 10.0 | |
| MPS Pharmaa Ltd | 3.98 Cr. | 2.08 | 2.08/1.57 | 0.04 | 0.00 % | 13.1 % | 177 % | 10.0 | |
| Evoq Remedies Ltd | 3.64 Cr. | 1.46 | 6.11/1.35 | 17.8 | 0.00 % | 0.56 % | 0.54 % | 10.0 | |
| Wockhardt Ltd | 35,661 Cr. | 2,194 | 2,422/1,087 | 89.4 | 304 | 0.00 % | 7.55 % | 6.11 % | 5.00 |
| J B Chemicals & Pharmaceuticals Ltd | 38,677 Cr. | 2,409 | 2,526/1,603 | 53.8 | 259 | 0.91 % | 25.4 % | 18.9 % | 1.00 |
| Ajanta Pharma Ltd | 45,239 Cr. | 3,621 | 3,797/2,379 | 39.9 | 362 | 0.88 % | 34.5 % | 27.1 % | 2.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 47,136 Cr. | 2,784 | 3,121/2,088 | 44.8 | 134 | 2.05 % | 61.4 % | 45.6 % | 10.0 |
| Ipca Laboratories Ltd | 49,151 Cr. | 1,938 | 2,039/1,252 | 35.8 | 318 | 0.31 % | 17.0 % | 15.7 % | 1.00 |
| Gland Pharma Ltd | 49,342 Cr. | 2,990 | 3,042/1,574 | 34.9 | 656 | 0.67 % | 17.4 % | 12.8 % | 1.00 |
| Abbott India Ltd | 57,908 Cr. | 27,270 | 30,655/25,135 | 35.9 | 2,247 | 1.93 % | 44.8 % | 34.4 % | 10.0 |
| Biocon Ltd | 60,188 Cr. | 370 | 447/338 | 82.8 | 210 | 0.14 % | 3.61 % | 1.40 % | 5.00 |
| Alkem Laboratories Ltd | 61,898 Cr. | 5,164 | 5,934/5,051 | 27.2 | 1,156 | 1.03 % | 21.2 % | 18.9 % | 2.00 |
| Glenmark Life Sciences Ltd | 68,601 Cr. | 2,442 | 2,538/1,793 | 22.0 | 372 | 0.20 % | 39.8 % | 23.6 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 68,601 Cr. | 2,442 | 2,538/1,793 | 22.0 | 372 | 0.20 % | 39.8 % | 23.6 % | 1.00 |
| Lupin Ltd | 93,847 Cr. | 2,052 | 2,530/1,900 | 15.8 | 491 | 0.88 % | 29.9 % | 28.7 % | 2.00 |
| Aurobindo Pharma Ltd | 97,538 Cr. | 1,698 | 1,740/1,066 | 25.8 | 652 | 0.24 % | 12.9 % | 10.1 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,04,365 Cr. | 1,252 | 1,415/1,080 | 32.4 | 454 | 0.64 % | 13.0 % | 11.2 % | 1.00 |
| Mankind Pharma Ltd | 1,04,950 Cr. | 2,545 | 2,642/1,910 | 46.4 | 397 | 0.04 % | 13.7 % | 13.8 % | 1.00 |
| Laurus Labs Ltd | 1,06,859 Cr. | 1,979 | 2,055/827 | 122 | 97.3 | 0.10 % | 16.0 % | 15.2 % | 2.00 |
| Cipla Ltd | 1,08,448 Cr. | 1,346 | 1,673/1,166 | 30.3 | 426 | 0.97 % | 15.5 % | 11.6 % | 2.00 |
| Torrent Pharmaceuticals Ltd | 1,86,137 Cr. | 4,894 | 5,250/3,480 | 83.4 | 248 | 0.78 % | 15.2 % | 27.4 % | 5.00 |
| Industry Average | 17,918.65 Cr | 1,271.04 | 56.14 | 211.60 | 0.38% | 26.16% | 16.59% | 6.06 |
How to use this peer comparison
Start with similar company sizes, then compare P/E with ROCE and ROE. A lower P/E alone does not establish better value. Negative earnings, unusual items, debt and different reporting dates can make ratios unsuitable for direct comparison.
The company list is ordered by market-cap proximity to Astrazeneca Pharma India Ltd, with P/E as a secondary comparison. The industry-average row uses available stored values across the industry, which can include companies beyond the rows shown. Missing values are not zero.
Open each company report for financial statements and its cited sources. Industry classifications indicate a research peer group, not a verified list of direct commercial competitors.
Read the full Astrazeneca Pharma India Ltd analysis · Explore all Pharmaceuticals stocks